You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 16 No. 5, May 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (260)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma Serotonin in Migraine and Stress

Michael Anthony, MB, MRACP; Herta Hinterberger, BSc, PhD; James W. Lance, MD, FRACP

Arch Neurol. 1967;16(5):544-552.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN 1961, Sicuteri, Testi, and Anselmi1 demonstrated that the excretion in the urine of 5-hydroxyindoleacetic acid (5HIAA), the principal catabolite of serotonin (5-hydroxytryptamine, 5HT), was increased during some attacks of migraine headache. This was confirmed by Curran, Hinterberger, and Lance2 in the majority of patients studied whereas Curzon, Theaker, and Phillips3 were able to find such a correlation in only two out of nine migrainous subjects.

Interest in the possible relationship of serotonin to the migraine syndrome had quickened following Sicuteri's preliminary trial of methysergide, a serotonin "antagonist," in the treatment of migraine.4 The value of methysergide maleate has since been established, although the mechanism of its action is still unexplained.5 Kimball, Friedman, and Vallejo6 were unable to produce headache in migrainous subjects by the injection of serotonin or its precursor 5-hydroxytryptophan. Indeed they found that injection of these substances relieved spontaneous migraine headaches. These . . . [Full Text PDF of this Article]


Author Affiliations

Sydney, New South Wales, Australia

From the divisions of neurology and clinical chemistry, Prince Henry Hospital, Sydney, and the School of Medicine, University of New South Wales, Australia. Dr. Anthony is a Sandoz Research Fellow in Neurology.


Footnotes

Submitted for publication Sept 13, 1966; accepted Dec 5.

Reprint requests to Division of Neurology, Prince Henry Hospital, Little Bay, New South Wales, Australia (Dr. Lance).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.